Revolutionizing Flu Care: Costs and Innovations

This chapter explores the potential savings from prioritizing primary care over costly hospitalizations and discusses the FDA's approval of a self-administered flu vaccine spray. It also examines the shift towards direct-to-consumer pharmaceuticals and the importance of improving flu vaccination rates, especially among children, to reduce overall health-related economic impacts.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app